iam Dr.Bharat Patodiya Absolutely, there are success stories where chemotherapy alone has been effective, particularly in patients with favorable risk leukemia types like t(8;21). This mutation is generally associated with better response rates to chemotherapy compared to other subtypes.

​

While every case is unique, with low-risk categories such as yours, standard chemotherapy regimens like cytarabine plus anthracycline (7+3 protocol) are often very effective. Many patients in this category achieve complete remission with induction chemotherapy alone and require only consolidation therapy afterward to maintain remission. 

​

It's promising to hear that you're classified in a low-risk group. However, please know that staying on top of regular follow-ups and monitoring for minimal residual disease (MRD) is crucial to tailoring further treatment decisions accurately. These advancements in monitoring have drastically improved outcomes as they allow for a very personalized approach.

​

If you'd like to explore this further or understand other experiences, feel free to connect. I work as the founder of Pi Cancer Care, where we frequently treat patients with acute myeloid leukemia. Hearing individual success stories firsthand reinforces the hope we see in practice every day. Please stay resilient—you’re asking thoughtful questions, which is a great step forward.